Systematic Ambulatory ECG Monitoring for Preventing Life-Threatening Cardiovascular Events Following TAVR
Circulation: Cardiovascular Interventions · 2026-08 · 19 (8)
DOI: 10.1161/circinterventions.125.016288 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Circulation: Cardiovascular Interventions, 2026-08. Verfasst von Quentin Fischer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Quebec Heart and Lung Institute, Laval University, QC, Canada. Hauptthemen laut MEDLINE: Electrocardiography, Ambulatory, Transcatheter Aortic Valve Replacement, Arrhythmias, Cardiac, Death, Sudden, Cardiac. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Although ambulatory ECG (AECG) monitoring has been assessed after transcatheter aortic valve replacement (TAVR), its impact on life-threatening cardiovascular events remains unclear. This study aimed to evaluate whether systematic AECG monitoring after TAVR reduces life-threatening cardiovascular events during the first year of follow-up. METHODS: The study included 1217 consecutive patients who underwent TAVR and were discharged without a permanent pacemaker. Of these, 211 consecutive patients received systematic 14-day AECG monitoring at discharge as part of the RECORD (Assessment of Arrhythmic Burden With Post-Procedural Continuous Electrocardiographic Monitoring in Patients Undergoing Transcatheter Aortic Valve Implantation) registry. The remaining 1006 patients who underwent TAVR within the 3 years before and after the registry period without systematic AECG monitoring constituted the control group. The primary end point was a composite of sudden cardiac death, syncope/presyncope due to symptomatic arrhythmias, or stroke at 1-year. RESULTS: Baseline and procedural characteristics were similar between groups, except for a higher use of self-expandable valves in the control group ( P =0.005). Systematic AECG monitoring was associated with a lower incidence of the primary endpoint (1.9% versus 6.6%; adjusted hazard ratio, 0.27 [0.10–0.74]; P =0.011), mainly driven by a lower rate of sudden death or arrhythmic syncope/presyncope (0.9% versus 4.0%; adjusted hazard ratio, 0.22 [0.05–0.89]; P =0.034). All sudden death cases occurred in the control group, at a median of 96 (33–235) days after TAVR. New-onset atrial fibrillation was diagnosed in 8.9% of the systematic AECG patients (versus 1.8% in the control group; adjusted hazard ratio, 5.31 [2.47–11.38]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Quebec Heart and Lung Institute, Laval University, QC, Canada.
ORCID-Profile: Quentin Fischer, Isabelle Nault, Pedro Cepas-Guillén, Marisa Avvedimento, Carla Benavent-Garcia, Emilie Pelletier-Beaumont, François Philippon, Josep Rodés-Cabau
Zitieren
APA
Fischer, Q., Nault, I., Cepas-Guillén, P., Avvedimento, M., Benavent-Garcia, C., Pelletier-Beaumont, E., Philippon, F., & Rodés-Cabau, J. (2026). Systematic Ambulatory ECG Monitoring for Preventing Life-Threatening Cardiovascular Events Following TAVR. Circulation: Cardiovascular Interventions, 19(8). https://doi.org/10.1161/circinterventions.125.016288
Vancouver
Fischer Q, Nault I, Cepas-Guillén P, Avvedimento M, Benavent-Garcia C, Pelletier-Beaumont E, et al. Systematic Ambulatory ECG Monitoring for Preventing Life-Threatening Cardiovascular Events Following TAVR. Circulation: Cardiovascular Interventions. 2026;19(8). doi:10.1161/circinterventions.125.016288
BibTeX
@article{Fischer2026,
author = {Fischer, Quentin and Nault, Isabelle and Cepas-Guillén, Pedro and Avvedimento, Marisa and Benavent-Garcia, Carla and Pelletier-Beaumont, Emilie and Philippon, François and Rodés-Cabau, Josep},
title = {Systematic Ambulatory ECG Monitoring for Preventing Life-Threatening Cardiovascular Events Following TAVR},
journal = {Circulation: Cardiovascular Interventions},
year = {2026},
volume = {19},
number = {8},
doi = {10.1161/circinterventions.125.016288}
}
EUVIMED